Aim: Serum high molecular weight (HMW) adiponectin improves insulin sensitivity, and a decreased level of serum HMW adiponectin has been reported as a risk factor for the development of diabetes and coronary heart disease. This association may be further confounded by the hemoglobin status, which is involved in the development of atherosclerosis. 
Introduction
Adiponectin, a 247-amino acid protein containing four differentiable domains, is secreted specifically by adipose tissue and regulates lipid and glucose metabolism 1) . A large number of studies have demonstrated that adiponectin exhibits anti-inflammatory, anti-diabetic, anti-atherogenic, anti-thrombotic, lipidoxidation enhancing, and vasodilatory properties [2] [3] [4] [5] . Moreover, it has been recently demonstrated that adiponectin forms multimers and is present in the serum as a trimer, hexamer, or as a HMW form, which is the most active form of this protein 6) . In non-diabetic or diabetic subjects, the HMW adiponectin value has better predicting power for insulin resistance and metabolic syndrome than plasma total adiponectin level [7] [8] [9] .
Increased hemoglobin values often accompany insulin resistance and compensatory hyperinsulinemia in humans [10] [11] [12] . Conversely, anemia has also been suggested to be responsible for insulin resistance 13) . Paradoxically, serum HMW adiponectin is elevated in patients with chronic kidney disease (CKD) which leads to severe anemia 14) . The current study aimed to investigate whether hemoglobin was independently associated with the serum level of high-molecular-weight (HMW) adiponectin. To our knowledge, few studies have demonstrated a relationship between hematological parameters, such as hemoglobin and serum HMW adiponectin 15, 16) . We hypothesized that hematological parameters are associated with serum HMW adiponectin regardless of insulin resistance and body weight. We evaluated whether there is an association with decreased adiponectin levels, using cross-sectional data on community-dwelling men.
Materials and Methods

Subjects
Participants were recruited at the time of their annual health examination in a rural town with a total population of 11,136 (as of April 2002) and located in Ehime prefecture, Japan, in 2002. Among the 9,133 adults (4,395 male) aged 19 to 90 years in this population, a random sample of 3,164 (34.6%) subjects was recruited. Information on medical history, present conditions, and drugs was obtained by interview. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Ehime University School of Medicine.
Evaluation of Risk Factors
Information on demographic characteristics and risk factors was collected using clinical files. Body mass index was calculated by dividing weight (in kilograms) by the square of the height (in meters). We measured blood pressure in the right upper arm of participants while in the sedentary position using an automatic oscillometric blood pressure recorder (BP103i; Colin, Aichi, Japan) after having rested for at least 5 min. Total cholesterol (T-C), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), uric acid, immunoreactive insulin (IRI), serum gamma glutamyltransferase (GGT), and high molecular weight (HMW) adiponectin (FU-JIREBIO, Tokyo, Japan) were measured during fasting. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from FBG and IRI levels using the following formula; FBG (mg/dL) X IRI (mU/mL)/405 17) and insulin resistance was defined as HOMA-IR ≥1.6 17) . . Other characteristics, e.g., smoking and alcohol drinking, and medication were investigated by individual interviews using a structured questionnaire. Smoking status was defined as the number of cigarette packs per day multiplied by the number of years smoked (pack year), and the daily alcohol consumption was measured using the Japanese liquor unit, in which a unit corresponds to 22.9 g ethanol.
Statistical analysis
Statistical analysis was performed using PASW Statistics 17.0 (Statistical Package for Social Science Japan, Inc., Tokyo, Japan). All values are expressed as the mean standard deviation (SD), unless otherwise specified. Data for TG, serum GGT, HOMA-IR, and serum HMW adiponectin were skewed and log-transformed for analysis. Differences based on quartiles of the hemoglobin status (Hemoglobin-1, 13 g/dL; Hemoglobin-2, 13.0-13.9 g/dL; Hemoglobin-3, 14.0-15.0g/dL; and Hemoglobin-4, 15.0 g/dL) were analyzed by ANOVA or chi-square ( 2 ) test. Pearson's partial correlations, after adjustment for age, were calculated in order to characterize associations between various characteristics and serum HMW adiponectin because the levels increased with age 9) . Multiple linear regression analysis was used to evaluate the contribution of each confounding factor for serum HMW adiponectin [19] [20] [21] [22] [23] [24] . ANCOVA was performed using a general linear model approach to determine the association between confounding factors and serum HMW adiponectin. In these analyses, serum HMW adiponectin was the dependent variable, the four categories of hemoglobin status were the fixed factors, and sex, age, BMI, alcohol consumption, smoking status, lipids, medication, and HOMA-IR were added as covariates. A value of P 0.05 was considered significant. Table 1 shows the characteristics of each subject's background factors categorized according to hemoglobin status. The subjects were 897 men aged 61 14 (mean standard deviation) (range, 20-89) years and 1,148 women aged 63 12. The prevalence of men, body mass index, alcohol consumption, smoking status, systolic blood pressure (SBP), diastolic blood pressure (DBP), TG, uric acid, serum GGT, and HOMA-IR was significantly higher but HDL-C levels were significantly lower with increased hemoglobin. The prevalence of antihypertensive medication and T-C was an inverted V shape. There were no inter-group differences regarding antilipidemic medication and antidiabetic medication.
Results
Mean serum HMW adiponectin levels were significantly lower with an increased hemoglobin level, and there were inter-group significances in subjects categorized by the hemoglobin status ( Table 2) . In all subjects, age-adjusted Pearson's partial correlation coefficient between confounding factors and serum HMW adiponectin showed that levels of serum HMW adiponectin were inversely associated with HDL, high-density lipoprotein; HOMA-IR, homeostasis of minimal assessment of insulin resistance; eGFR, estimated glomerular filtration rate. Data presented are the mean standard deviation. Data for triglycerides, serum gamma glutamyltransferase, and HOMA-IR were skewed, and are presented as median (interquartile range) values. Alcohol consumption was measured using a Japanese liquor unit where 1 unit corresponds to 22.9 g ethanol (never drinkers, light drinkers ( 1 unit/day), moderate drinkers (1-2 unit/day), and heavy drinkers (≥2 unit/day)). Smoking status: daily consumption (pack) duration of smoking (year) (never smokers, ex-smokers, light smokers ( 30 pack year), and heavy smokers (≥30 pack year)). P-value: ANOVA or 2 test. P 0.001 P 0.001 P 0.001
BMI, alcohol consumption, smoking status, SBP, DBP, antihypertensive medication, TG, antilipidemic medication, uric acid, serum GGT, HOMA-IR, and hemoglobin, but directly associated with sex, HDL-C and eGFR (Table 3) . To further investigate whether the hemoglobin status can explain changes in serum HMW adiponectin levels independent of other known confounding factors, multiple linear regression analyses for serum HMW adiponectin were performed with four models ( Table 4 ). The hemoglobin status was shown to be independently and significantly associated with serum HMW adiponectin levels as well as sex, age, BMI, alcohol consumption, T-C, TG, HDL-C, antilipidemic medication, uric acid, serum GGT, and HOMA-IR (model 4: stepwise method). Inclusion of hemoglobin levels (model 3 or model 4) in the model further increased the coefficient of determination (R 2 ). Fig. 1 presents the log levels of serum HMW adiponectin after adjustment for confounding factors in Model 4 of Table 4 . Serum HMW adiponectin levels were significantly lowest in subjects with a hemoglobin level of 15.0 g/dL.
Next, to control potential confounding by sex, age, obesity, alcohol consumption and insulin resistance, the data were further stratified by sex, age, BMI, alcohol consumption, and HOMA-IR ( Table 5) . Mean log serum HMW adiponectin levels significantly and similarly decreased with increased hemoglobin levels in those aged ≥65 years, BMI 23.0 kg/m 2 , alcohol drinkers, and HOMA-IR 1.6 groups, and there were significant interactions between the two groups for BMI, alcohol consumption and HOMA-IR; however, there were no interactions between the two groups for sex and age.
Discussion
To examine the possible contribution of the hemoglobin status to serum HMW adiponectin levels in community-dwelling persons, we studied the relationship between potential confounders and the serum HMW adiponectin level in various hemoglobin status groups. Multiple linear regression analyses for serum HMW adiponectin revealed that the hemoglobin status was significantly associated with serum HMW adiponectin levels as well as age, BMI, alcohol consumption, and HOMA-IR. The present study also showed a dose-dependent relationship between hemoglobin levels and serum HMW adiponectin levels in Japanese community-dwelling persons. HMW, high molecular weight; HDL, high-density lipoprotein; HOMA-IR, homeostasis of minimal assessment of insulin resistance; eGFR, estimated glomerular filtration rate. Alcohol consumption was measured using a Japanese liquor unit where 1 unit corresponds to 22.9 g ethanol (never drinkers, light drinkers ( 1 unit/day), moderate drinkers (1-2 unit/day), heavy drinkers (≥2 unit/day)). Smoking status: daily consumption (pack) duration of smoking (year) (never smokers, ex-smokers, light smokers ( 30 pack year), heavy smokers (≥30 pack year)). Data for triglycerides, serum gamma glutamyltransferase, HOMA-IR, and serum HMW adiponectin were skewed, and log-transformed for analysis. r, Pearson's correlation coefficient. 
HMW, high molecular weight; HDL, high-density lipoprotein; HOMA-IR, Homeostasis of minimal assessment of insulin resistance; eGFR, estimated glomerular filtration rate. Alcohol consumption was measured using a Japanese liquor unit where 1 unit corresponds to 22.9 g ethanol (never drinkers, light drinkers ( 1 unit/day), moderate drinkers (1-2 unit/day), heavy drinkers (≥2 unit/day)). Smoking status: daily consumption (pack) duration of smoking (year) (never smokers, ex-smokers, light smokers ( 30 pack year), heavy smokers (≥30 pack year)). Data for triglycerides, serum gamma glutamyltransferase, HOMA-IR, and serum HMW adiponectin were skewed and log-transformed for analysis. , standard coefficient. Model 4: stepwise method. Fig. 1 . Multivariate-adjusted mean log serum HMW adiponectin of the subjects categorized by hemoglobin status.
HMW, high molecular weight. Data presented are the log-transformed mean (95% confidence interval) values. Data for triglycerides, HOMA-IR, and serum HMW adiponectin, are skewed and log-transformed for analysis. Multivariate-adjusted for confounding factors in model 4 in Table 4 .
In this study, the relationship between serum adiponectin levels and confounding factors was consistent with previous studies in that serum adiponectin was significantly associated with age, BMI, blood pressure 25) , TG, HDL-C 20) , FBG, HOMA-IR 19) , and eGFR 22) . Serum adiponectin has been demonstrated to play a key role in dyslipidemia 20) and insulin resistance 19) , and those levels are decreased by obesity, and increased by medications such as thiazolidinedione compounds 26) , angiotensin converting enzyme inhibitors, and angiotensin receptor blockers 27) , which improve insulin sensitivity at the cellular level. We therefore used multiple regression analysis to examine the association between the hemoglobin status and serum HMW adiponectin with adjustments made for age, BMI, alcohol consumption, smoking status, lipids, serum GGT, HOMA-IR, eGFR, and antihypertensive, antilipidemic, and antidiabetic medications.
Few studies have demonstrated a relationship between hemoglobin and serum HMW adiponectin. Thus far, the mechanisms that lead to hypoadiponectinemia with elevated hemoglobin levels are not completely understood. Hemoglobin is the main carrier and buffer of nitric oxide 28) . Hemoglobin, which relates to iron metabolism, is an extremely active oxidant, and met-hemoglobin exerts its oxidative activity on LDL via the transfer of heme, which serves as a vehicle for iron insertion into the LDL protein 29) . In the prediabetic stage, subjects with higher hemoglobin levels exhibited lower HDL-C and higher blood pressures and elevated levels of soluble CD40L, which is a pro-inflammatory cytokine, and hemoglobin was an independent determinant of soluble CD40L levels 30) . A recent study suggested that oxidative LDL may play this role 31) . Facchini et al. also demonstrated that hemoglobin is independently related to insulin resistance and compensatory hyperinsulinemia also in healthy, nonobese men and women 10) . In an insulin-resistant state, more TNF-may be produced and dose-dependently suppress the expression of adiponectin in adipocytes by suppressing their promoter activity 32) . This provides a plausible explanation for our findings in that we also observed a dose-dependent and inverse relationship between the hemoglobin level and serum HMW adiponectin. In our study, hemoglobin per se was associated with other comorbidities, such as increased BMI, alcohol consumption, smoking status, blood pressure, TG, uric acid, and HOMA-IR, and decreased HDL-C. All these risk factors relate to insu- Table 4 . a P 0.05 and A P 0.01, hemoglobin-1 vs hemoglobin-4; b P 0.05 and B P 0.01, hemoglobin-1 vs hemoglobin-3; c P 0.05, hemoglobin-1 vs hemoglobin-2; d P 0.05, hemoglobin-2 vs hemoglobin-4 lin resistance 33) and result in endothelial dysfunction 34) . Furthermore, in our study, the hemoglobin status was inversely associated with decreased serum HMW adiponectin levels, especially in participants with BMI 23.0 kg/m 2 , alcohol drinkers, and HOMA-IR 1.6, in which insulin resistance was lower 33) . The effect of hemoglobin on serum HMW adiponectin levels may occur easily in these groups.
Some limitations of this study must be considered. First, the response rate was low, 35%, which is commonly observed in other conventional community studies in Japan. However, the relatively large sample size enabled the assessment of an extensive array of hemoglobin status in relation to serum HMW adiponectin. Second, the cross-sectional study design is limited in its ability to eliminate causal relationships between the hemoglobin status and serum HMW adiponectin. Third, a single assessment of serum HMW adiponectin levels may be susceptible to short-term variation and this may introduce a misclassification bias. Finally, in this study, the demographics and referral source may limit the generalization of the results.
In conclusion, the present study showed that the hemoglobin status was associated with decreased serum HMW adiponectin in community-dwelling persons independent of traditional cardiovascular risk factors such as age, alcohol consumption, HOMA-IR, and eGFR. For community-dwelling persons, prospective population-based studies are needed to investigate the underlying mechanisms of this association.
